Skip to content

Stenger Family Office, LLC: CENT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Stenger Family Office, LLC on CENT, newest first. How the timeline and the estimate are built.

Stenger Family Office, LLC held 24,611 CENT shares at 2026-06-30 per its 13F-HR filed 2026-07-13.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 24,611 shares
    Change vs previous 13F +770 shares

    0.97% of the 13F portfolio, value $6,112,641.

    13F-HR 0002085853-26-000698 filed by Stenger Family Office, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 23,841 shares
    Change vs previous 13F +23,841 shares

    1.18% of the 13F portfolio, value $6,657,599.

    13F-HR 0002085853-26-000535 filed by Stenger Family Office, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -14,433 shares

    13F-HR 0002085853-26-000294 filed by Stenger Family Office, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2025-09-30
    13F 14,433 shares
    Change vs previous 13F +13,072 shares

    1.16% of the 13F portfolio, value $5,645,468.

    13F-HR 0002085853-25-000188 filed by Stenger Family Office, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,361 shares
    Change vs previous 13F not available

    0.12% of the 13F portfolio, value $469,912.

    13F-HR 0001667731-25-001113 filed by Stenger Family Office, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).